Shanghai Zerun Biotechnology (ZerunBio) and its parent company Walvax Biotechnology have partnered with Norway-based CEP...
Indian firm Intas Pharmaceuticals has entered into an exclusive license agreement with Japan-based Meiji and South Korea...
Takeda Pharmaceutical has announced an additional agreement with Moderna and the Government of Japan’s Minist...
US-based Regeneron Pharmaceuticals has announced that Japan's Ministry of Health, Labour and Welfare (MHL...
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...
Kintor Pharmaceutical has announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical De...
Aptamer Group, the UK-based developer of Optimer therapeutics and diagnostics, has secured a contract with a top-five gl...
SINOVAC Biotech, a leading provider of biopharmaceutical products in China, announced that it has signed an advance purc...
UK government announced on July 8, 2021, that a new drugs unit will be set up to help end illegal drug-related illness a...
RauCon, the Heidelberg, Germany, based pharma business development service provider for the global...
Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Kwon J...
Japanese firm Takeda has announced ILLUMINATE - a rare disease diagnosis program to support improved clinical resul...
Japanese firms Chugai Pharmaceutical Co., Ltd. and ALBERT Inc, have jointly developed a data scientist training program ...
Triastek, Inc., the first 3D printing pharmaceutical company in China, has completed its Series B financing, raisin...
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advan...
In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26...
Kite, a Gilead Company, has announced that Fosun Kite Biotechnology Co., Ltd., a joint venture between Kite and Shanghai...
Multinational consultancy firm based in Dublin, Linesight, announced that the collaboration it is leading with major glo...
Phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured b...
Germany-based Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation researc...
Perlara PBC, a rare disease public benefit company announced a rare genetic diseases collaboration with Vivan Therapeuti...
OPTEL, a Canada-based global provider of supply chain traceability technologies, has launched OPTEL IdentifAI™, th...
Japanese pharma firm Daiichi Sankyo Company has announced that it has decided to discontinue development of nafamostat i...
Brain diseases are the greatest contributor to the global burden of diseases, comparable to the impact of cardiovascular...
Coriolis Pharma announced that Prof Dr Ernst Wagner has joined its scientific advisory board. Prof Wagner’s distin...
